Envisagenics

Envisagenics is a biotechnology company that has developed a unique platform called SpliceCore to identify, test, and validate drug targets.

Headquarters

Year Founded

Company Status

Website

Sector

Operating Status

Social Media

Search Tags

AI biotechnology, RNA therapeutics, machine learning

About Us

Envisagenics is an AI-driven biotechnology company that specializes in RNA splicing research and therapeutic development. They use their proprietary platform, which combines artificial intelligence and machine learning, to analyze RNA sequencing data and identify novel RNA splicing variants associated with diseases.

Trending Companies in AI

Latest Articles in AI

Medicare will pilot AI-driven prior authorization in 2026 across six states, targeting high-risk services while clinicians make final decisions.

AI-Powered Prior Authorization Comes to Traditional Medicare

Traditional Medicare will pilot AI-assisted prior authorization in 2026 across six states, focusing on high-risk outpatient services. Clinicians retain final say, but incentives and access concerns loom as CMS tests fraud reduction and “gold card” exemptions. Here’s what providers and patients should know.

Read More >
Anycubic Photon Mono M7 Pro for $469 with code AC30OFF. FREE $99 Gifts: 1*High Speed Resin+2*FEP Film+3000pcs Limited Mystery Box

CREATORS. DISRUPTORS. INNOVATORS.

Discover Emerging Technology Companies